| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.8M | +4302.0% |
| Cost of Revenue | $9.4M | +2165.5% |
| Gross Profit | -$643K | -196.3% |
| R&D Expense | $13.5M | +276.2% |
| SG&A Expense | $29.8M | +703.8% |
| Operating Income | -$44.0M | -485.2% |
| Pre-tax Income | -$137.4M | -1747.6% |
| Income Tax | $2K | — |
| Net Income | -$137.4M | -1747.6% |
| EPS (Basic) | -$11.48 | -1134.4% |
| EPS (Diluted) | -$11.48 | -1134.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $190.1M | +936.8% |
| Accounts Receivable | $900K | — |
| Inventory | $32.3M | — |
| Current Assets | $227.2M | +1123.1% |
| Total Assets | $257.4M | — |
| Current Liabilities | $12.5M | — |
| Long-term Debt | $35K | -59.8% |
| Total Liabilities |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.1M | -343.5% |
| Capital Expenditures | $3.8M | +1200.3% |
| Investing Cash Flow | -$38.6M | — |
| Financing Cash Flow | $242.9M | +2173.5% |
| Free Cash Flow | -$34.9M | -378.2% |
| $43.4M |
| — |
| Stockholders' Equity | $214.1M | — |